GGrantIndex
← Leaderboards

Boston University (Charles River Campus)

Boston, MA

Compare ↔
$1,029,403,028
Total funding
843
Grants

Funding over time

peak $82.2M · FY2006–25
$100M$75M$50M$25M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,030,471,406 · 840
AHRQ$1,220,269 · 2
SAMHSA$0 · 2

By mechanism

R01$611,546,512 · 299
R21$51,005,581 · 117
P50$50,230,783 · 33
R35$46,098,441 · 18
U01$28,582,942 · 10
N01$26,958,966 · 4

Investigators at Boston University (Charles River Campus)

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Michael B Albro$2,974,4842 gr2Timothy Mark O'Shea$2,178,6264 gr3Chen Yang$1,734,5183 gr4Ana Fiszbein$1,650,0001 gr5Alberto Cruz-Martin$1,569,0001 gr6Roberto Paiella$613,1241 gr7Mads Sylvest Bergholt$557,3321 gr8Amelia M. Stanton$553,8933 gr

Emerging Leaders

6–10 yrs in

1Todd J. Farchione$6,377,2843 gr2Naomi K. Caselli$3,830,3102 gr3Virginia Ann Best$3,550,3512 gr4Daniel C Fulford$3,534,7555 gr5Daryush Dinyar Mehta$3,344,8583 gr6Uwe Beffert$3,207,8652 gr7Mark W Howe$3,038,3251 gr8Allison Marie Dennis$2,968,6113 gr

All-Time

Most funded here, all years

1Ji-Xin Cheng$30,661,50525 gr2Mark W Grinstaff$20,416,96429 gr3John A Porco$17,197,3738 gr4Sangeeta N. Bhatia$16,374,0458 gr5Pierre E Dupont$15,192,1466 gr6Xue Han$13,851,83912 gr7Jerome C Mertz$13,245,51418 gr8Elise F Morgan$12,341,0465 gr

Largest grants

Final clinical studies for submission of a pre-market approval application to the FDA for a Bionic Pancreas that automates type 1 diabetes management$11,957,319
UC4 · FY2016 · DK
FRAMINGHAM HEART STUDY (FHS), TASK AREA A - CORE STUDY OPERATIONS$6,618,783
N01 · FY2025 · HL
Laboratory renovation for translational synthetic and medicinal chemistry$5,882,526
C06 · FY2010 · RR
A multicenter outpatient trial of a bihormonal bionic pancreas$2,880,000
DP3 · FY2013 · DK
Unveiling Hidden Signatures in Life by Vibrational Photothermal Microscopy$2,811,668
R35 · FY2025 · GM
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY$2,805,263
N01 · FY2011 · HL
Local Neuronal Drive and Neuromodulatory Control of Activity in the Pial Neurovascular Circuit$2,784,416
U19 · FY2023 · NS
Local neuronal drive and neuromodulatory control of activity in the pial neurovascular circuit$2,774,791
U19 · FY2022 · NS
Local neuronal drive and neuromodulatory control of activity in the pial neurovascular circuit$2,717,308
U19 · FY2021 · NS
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators$2,680,864
UF1 · FY2018 · NS
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY$2,644,410
N01 · FY2010 · HL
Complex Chemotypes: Discovery, Methodology, and Library Expansion$2,567,597
P50 · FY2008 · GM
Local Neuronal Drive and Neuromodulatory Control of Activity in the Pial Neurovascular Circuit$2,564,400
U19 · FY2025 · NS
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY$2,521,819
N01 · FY2014 · HL
Local Neuronal Drive and Neuromodulatory Control of Activity in the Pial Neurovascular Circuit$2,520,071
U19 · FY2024 · NS
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY$2,516,589
N01 · FY2012 · HL
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder$2,506,654
P50 · FY2019 · DC
Combatting antibiotic resistance with synthetic biology technologies$2,472,375
DP2 · FY2016 · AI
Synthetically Reengineered T cells as the Next Generation of Smart Cancer Therapy$2,455,500
DP2 · FY2013 · CA
Light-Actuatable NanoRobots for Molecular Uncaging$2,455,500
DP2 · FY2012 · NS